logo
F19 logo
lifestyle_sidebar
More Basic Research Reports
F19 Survives the Upper GI Tract
Figure8Lactobacillus F19 has been shown to be an effective probiotic culture. It can survive the upper GI tract, which is not surprising considering F19 can grow in the presence of human bile. MRS media was supplemented with 0.3, 0.5, and 5.0 % human bile and was inoculated with Lactobacillus F19 (Figure 8). F19 grew in all concentrations of bile tested. In another experiment, F19 even survived for 2 hours in MRS broth with 20% ox gall added. It also has been shown that F19 grows in the presence of bile without deconjugating bile salts.
In addition, Ljungh et al (2002) showed that F19 could survive in lower pH ranges. Lactobacillus F19 was added to MRS broth adjusted to a pH of 2.5 using 1 M HCl. F19 survived for one hour when incubated at 30oC (86oF).                                                Figure 8.  Fecal counts of Lactobacillus F19
                                                         in
elderly treatment participants.

Knowing that the adverse environment of the stomach was no obstacle for
Lactobacillus
F19, Ljungh et al also testing the binding affinities of the culture.
It was determined that F19 had a 
high surface hydrophobicity. It has excellent
adhesion
to mucin, collagens I and III, fibrinogen, heparin, and fibronectin.
Kapczynski et al (2000) 
correlated fibronectin binding ability to adherence
of bacteria to intestinal lining cells. Thus, F19 has the ability to colonize the
GI tract.

For More Information... Contact Us
Medipharm believes we have considerable information detailing the research and development efforts necessary to launch Lactobacillus F19 into the probiotic marketplace.  This documentation makes F19 one of the most completely-researched strains available for incorporation into functional foods and supplements.  Copies of the studies summarized and presented here, as  well  as  numerous other published reports, are available on request.  We encourage you to contact us in order to provide all information necessary to allow for an educated decision when it comes to selecting a probiotic culture.  The technology represented here has been sufficient to grant a U.S patent for Lactobacillus F19 in July of 2003 (US Patent Number 6,599,504).   When it comes to beneficial bacteria for better health, consider Medipharm.

For general inquiries, more information, copies of documented research, or answers to commonly asked questions, contact us!

Tom Wiersum, Product Manager, Food & Nutrition

Call 1-800-397-5689  Ext 209 or e-mail inquiries to:  twiersum@medipharmusa.com

   

Page 1 , 2 , 3 , 4 , 5 , 6 ,7
Next
Home
Medipharm USA    Phone: 1.800.397.5689
10215 Dennis Dr.       Fax: 1.515.254.1356
Des Moines, IA 50322

E-mail:mphinfo@medipharmusa.com